These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8341299)

  • 1. Cisapride treatment of constipation in Parkinson's disease.
    Jost WH; Schimrigk K
    Mov Disord; 1993 Jul; 8(3):339-43. PubMed ID: 8341299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson's disease.
    Jost WH; Schimrigk K
    Wien Klin Wochenschr; 1994; 106(21):673-6. PubMed ID: 7810153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results with cisapride in Parkinson's disease.
    Jost WH; Schimrigk K
    Mov Disord; 1997 May; 12(3):423-5. PubMed ID: 9159740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cisapride on response fluctuations in Parkinson's disease.
    Djaldetti R; Koren M; Ziv I; Achiron A; Melamed E
    Mov Disord; 1995 Jan; 10(1):81-4. PubMed ID: 7885359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisapride accelerates colonic transit in constipated patients with colonic inertia.
    Fink S; Chaudhuri TK; Palmer JD
    Am J Gastroenterol; 1990 Feb; 85(2):216-7. PubMed ID: 2301347
    [No Abstract]   [Full Text] [Related]  

  • 6. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.
    Liu Z; Sakakibara R; Odaka T; Uchiyama T; Uchiyama T; Yamamoto T; Ito T; Asahina M; Yamaguchi K; Yamaguchi T; Hattori T
    Mov Disord; 2005 Jun; 20(6):680-6. PubMed ID: 15719424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic constipation. Use of cisapride].
    Uzcategui Arauz A; Arias Guzman Y; Jaen D
    G E N; 1995; 49(3):218-23. PubMed ID: 8598260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of cisapride on the chronic constipation of paraplegia.
    Binnie NR; Creasey GH; Edmond P; Smith AN
    Paraplegia; 1988 Jun; 26(3):151-8. PubMed ID: 3419860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease.
    Neira WD; Sanchez V; Mena MA; de Yebenes JG
    Mov Disord; 1995 Jan; 10(1):66-70. PubMed ID: 7885357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
    Zangaglia R; Martignoni E; Glorioso M; Ossola M; Riboldazzi G; Calandrella D; Brunetti G; Pacchetti C
    Mov Disord; 2007 Jul; 22(9):1239-44. PubMed ID: 17566120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride accelerates colonic transit in constipated patients with colonic inertia.
    Krevsky B; Maurer AH; Malmud LS; Fisher RS
    Am J Gastroenterol; 1989 Aug; 84(8):882-7. PubMed ID: 2667336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cisapride on segmental colonic transit time in patients with spinal cord injury.
    Geders JM; Gaing A; Bauman WA; Korsten MA
    Am J Gastroenterol; 1995 Feb; 90(2):285-9. PubMed ID: 7847302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cisapride on constipation due to a neurological lesion.
    de Groot GH; de Pagter GF
    Paraplegia; 1988 Jun; 26(3):159-61. PubMed ID: 3419861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Encouragement for the tired stomach. Cisapride, a specific pro-kinetic drug for upset stomach].
    Fortschr Med Suppl; 1990; 87():7-12. PubMed ID: 2351360
    [No Abstract]   [Full Text] [Related]  

  • 15. Constipation in Parkinson's disease: objective assessment and response to psyllium.
    Ashraf W; Pfeiffer RF; Park F; Lof J; Quigley EM
    Mov Disord; 1997 Nov; 12(6):946-51. PubMed ID: 9399219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of obstipation].
    Ewe K
    Dtsch Med Wochenschr; 1989 Dec; 114(49):1924-6. PubMed ID: 2686957
    [No Abstract]   [Full Text] [Related]  

  • 17. Cisapride stimulates small intestinal motility and relieves constipation in myelopathy due to cervical spinal stenosis: case report.
    Hellström PM; Aly A; Johansson C
    Paraplegia; 1990 May; 28(4):261-4. PubMed ID: 2235032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
    Cadeddu F; Bentivoglio AR; Brandara F; Marniga G; Brisinda G; Maria G
    Aliment Pharmacol Ther; 2005 Nov; 22(10):997-1003. PubMed ID: 16268975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autonomic nervous system dysfunction in Parkinson's disease evaluated by the heart rhythm variability test].
    Krygowska-Wajs A; Grabowska-Maślanka H; Tabor S; Sobocki J; Szczudlik A; Thor P
    Folia Med Cracov; 1997; 38(3-4):47-52. PubMed ID: 10481381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisapride for the treatment of chronic idiopathic constipation.
    Gardner VY; Beckwith JV; Heyneman CA
    Ann Pharmacother; 1995 Nov; 29(11):1161-3. PubMed ID: 8573964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.